Table 2 Patterns of Large Vessel Occlusions comparing patients with DOAC and VKA pretreatment
DOAC pretreatment (N = 75) | VKA pretreatment (N = 61) | P | Confirmed therapeutic DOAC (N = 35) | Confirmed therapeutic VKA (N = 45) | P | |
|---|---|---|---|---|---|---|
Any large vessel occlusion | 22/75 (29.3%) | 23/61 (37.7%) | 0.361 | 9/35 (25.7%) | 14/45 (31.1%) | 0.628 |
- Proximal ICA | 1 (4.5%) | 1 (4.3%) | 0 | 0 | ||
- Carotid-T | 2 (9.1%) | 2 (8.7%) | 1 (11.1%) | 1 (7.1%) | ||
- Proximal M1 | 7 (31.8%) | 4 (17.4%) | 3 (33.3%) | 1 (7.1%) | ||
- Distal M1 | 3 (13.6%) | 1 (4.3%) | 1 (11.1%) | 1 (7.1%) | ||
- M2 | 6 (27.3%) | 6 (26.1%) | 3 (33.3%) | 4 (28.6%) | ||
- M3 | 0 | 1 (4.3%) | 0 | 1 (7.1%) | ||
- A1 | 0 | 0 | 0 | 0 | ||
- A2 | 1 (4.5%) | 0 | 0 | 0 | ||
- V4 | 0 | 1 (4.3%) | 0 | 1 (7.1%) | ||
- BA | 0 | 0 | 0 | 0 | ||
- P1 | 0 | 1 (4.3%) | 0 | 1 (7.1%) | ||
- P2/3 | 1 (4.5%) | 4 (17.4%) | 0 | 4 (28.6%) | ||
- Multiple | 1 (4.5%) | 1 (4.3%) | 1 (11.1%) | 0 | ||
- SCA | 0 | 1 (4.3%) | 0 | 0 | ||
Potential target large vessel occlusion for EVT | 20/75 (26.7%) | 17/61 (27.9%) | 1.000 | 9/35 (25.7%) | 9/45 (20.0%) | 0.596 |